Results
1 -
10 of
30
(Click
here to explore results)
- Drug Discovery for Psychiatric Disorders, CHAPTER 10 Glutamate Approaches Towards the Treatment of Mood Disorders. Carrie K. Jones, P. Jeffrey Conn, Craig W. Lindsley
, 2012
, Pages 258-275
- Drug Discovery for Schizophrenia, CHAPTER 6 Drugs that Target the Glutamate Synapse: Implications for the Glutamate Hypothesis of Schizophrenia. Catharine A. Mielnik, Amy J. Ramsey
, 2015
, Pages 115-140
- Drug Discovery for Psychiatric Disorders, CHAPTER 4 Glutamatergic Approaches for the Treatment of Schizophrenia. John A. Morrow, Robert Gilfillan, Stuart A. Neale
, 2012
, Pages 56-98
- Allosterism in Drug Discovery, CHAPTER 13 Mechanism of Action of a GluN2C- and GluN2D-Selective NMDA Receptor Positive Allosteric Modulator. Katie L. Strong, Matthew P. Epplin, Yao Jing, Stephen F. Traynelis, Dennis C. Liotta
, 2017
, Pages 281-309
- Emerging Drugs and Targets for Parkinson's Disease, CHAPTER 10 Glutamate Receptor Modulators as Emergent Therapeutic Agents in the Treatment of Parkinson’s Disease. Sylvain Célanire, Benjamin Perry, Robert Lutjens, Sonia Poli, Ian J. Reynolds
, 2013
, Pages 237-265
- Toxicological Effects of Veterinary Medicinal Products in Humans: Volume 2, CHAPTER 10 Organophosphorus Veterinary Medicines. Timothy C. Marrs
, 2013
, Volume 2
, Pages 33-70
- Acute Brain Impairment: Scientific Discoveries and Translational Research, Chapter 9 Advances in Diagnostics and Treatment of Neurotoxicity after Sports-related Injuries. Thomas A. Gennarelli, Svetlana A. Dambinova, Joseph D. Weissman
, 2018
, Pages 141-161
- Allosterism in Drug Discovery, CHAPTER 8 Muscarinic Receptors Allosteric Modulation. Bruce J. Melancon, Corey R. Hopkins
, 2017
, Pages 175-193
- Manganese in Health and Disease, Chapter 18 A Decade of Studies on Manganese Neurotoxicity in Non-Human Primates: Novel Findings and Future Directions. Tomás R. Guilarte
, 2015
, Pages 459-476
- Nuclear Magnetic Resonance: Volume 46, NMR in living systems. M. J. W. Prior
, 2021
, Volume 46
, Pages 272-322